Literature DB >> 376560

Antipili antibody affords protection against experimental ascending pyelonephritis.

F J Silverblatt, L S Cohen.   

Abstract

The ability of antipili antibody to prevent ascending urinary tract infection was investigated in rats. One group of rats was immunized passively with rabbit antisera to purified pili and challenged by intravesicular inoculation of 5 x 10(7) heavily piliated Escherichia coli. Only 2 of 14 immunized animals developed cortical abscesses as compared to 13 of 15 control rats given normal rabbit serum (P equals 0.0001). The mean log titer of bacteria in the kidneys of the immunized rats was 0.85 vs. 6.08 in the controls (P less than 0.005). A second group was actively immunized with pili. 3 of 16 immunized animals became infected as compared to 10 of 15 controls (P equals 0.01). The mean log titers were 2.13 and 4.54, respectively (P less than 0.01). A third group was passively immunized and challenged with a strain that had different O, K, and H antigens but shared pili antigens. Abscesses occurred in 4 of 15 immunized animals as compared to 13 of 15 controls (P equals 0.001). The mean log titers were 2.37 and 5.63, respectively (P less than 0.005). These results indicate that antipili antibody protects rats against ascending urinary tract infections.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 376560      PMCID: PMC372123          DOI: 10.1172/JCI109458

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  The immunologic basis of recurrent bacteriuria: role of cervicovaginal antibody in enterobacterial colonization of the introital mucosa.

Authors:  T A Stamey; N Wehner; G Mihara; M Condy
Journal:  Medicine (Baltimore)       Date:  1978-01       Impact factor: 1.889

2.  Immobilizing antibodies in urine. II. Prevention of ascending spread of Proteus mirabilis.

Authors:  G J Pazin; A I Braude
Journal:  Invest Urol       Date:  1974-09

3.  Experimental hematogenous pyelonephritis due to Escherichia coli in rabbits: the antibody response and its protective capacity.

Authors:  B Kaijser; S Olling
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

4.  Rapid detection of Australia-SH antigen and antibody by a simple and sensitive technique of immunoelectronmicroscopy.

Authors:  A E Kelen; A E Hathaway; D A McLeod
Journal:  Can J Microbiol       Date:  1971-07       Impact factor: 2.419

5.  Studies of introital colonization in women with recurrent urinary infections. VII. The role of bacterial adherence.

Authors:  J E Fowler; T A Stamey
Journal:  J Urol       Date:  1977-04       Impact factor: 7.450

6.  Immunization of suckling pigs against enteric enterotoxigenic Escherichia coli infection by vaccinating dams with purified pili.

Authors:  B Nagy; H W Moon; R E Isaacson; C C To; C C Brinton
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

7.  Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells.

Authors:  C S Edén; H A Hansson
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

8.  Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascending Escherichia coli pyelonephritis without bacteremia in rats.

Authors:  S J Brooks; J M Lyons; A I Braude
Journal:  Am J Pathol       Date:  1974-02       Impact factor: 4.307

9.  Type I Escherichia coli pili: characterization of binding to monkey kidney cells.

Authors:  I E Salit; E C Gotschlich
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

10.  Host-parasite interaction in the rat renal pelvis: a possible role for pili in the pathogenesis of pyelonephritis.

Authors:  F J Silverblatt
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more
  43 in total

1.  Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.

Authors:  K Thankavel; B Madison; T Ikeda; R Malaviya; A H Shah; P M Arumugam; S N Abraham
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Urinary antibody response after immunisation with a vaccine against urinary tract infection.

Authors:  D Kruze; K Holzbecher; M Andrial; W Bossart
Journal:  Urol Res       Date:  1989

3.  Escherichia coli K1 RS218 interacts with human brain microvascular endothelial cells via type 1 fimbria bacteria in the fimbriated state.

Authors:  Ching-Hao Teng; Mian Cai; Sooan Shin; Yi Xie; Kee-Jun Kim; Naveed Ahmed Khan; Francescopaolo Di Cello; Kwang Sik Kim
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors.

Authors:  S N Abraham; J P Babu; C S Giampapa; D L Hasty; W A Simpson; E H Beachey
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

5.  Utilization of anion-exchange chromatography and monoclonal antibodies to characterize multiple pilus types on a uropathogenic Escherichia coli O6 isolate.

Authors:  R M Gander; V L Thomas
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

6.  Population shift in mannose-specific fimbriated phase of Klebsiella pneumoniae during experimental urinary tract infection in mice.

Authors:  M C Maayan; I Ofek; O Medalia; M Aronson
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  The PapG tip adhesin of P fimbriae protects Escherichia coli from neutrophil bactericidal activity.

Authors:  R Tewari; T Ikeda; R Malaviya; J I MacGregor; J R Little; S J Hultgren; S N Abraham
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Serological response to Escherichia coli pili in pyelonephritis.

Authors:  P Rene; F J Silverblatt
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

9.  Attachment of pathogenic Neisseria to human mucosal surfaces: role in pathogenesis.

Authors:  D S Stephens; Z A McGee; M A Melly; L H Hoffman; C R Gregg
Journal:  Infection       Date:  1982       Impact factor: 3.553

10.  Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine.

Authors:  I Ofek; A Mosek; N Sharon
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.